Lantern Pharma (LTRN) Reports Q1 Loss of $0.42

May 15, 2025 5:03 PM

Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.42).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.